Induction of Alternative Splicing and Inhibition of Activity of Telomerase Catalytic Subunit by Apoptotic Endonuclease EndoG in Human T, B, and NK Cells


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The effect of apoptotic endonuclease EndoG on alternative splicing of mRNA of human telomerase catalytic subunit hTERT (human telomerase reverse transcriptase) and telomerase activity in normal human lymphocytes were studied. Human CD4+, CD8+, B, and NK cells were transfected with a plasmid pEndoG-GFP containing EndoG gene or control plasmid pGFP. The levels of mRNA of EndoG or hTERT splicing variants were analyzed by real-time PCR. Protein content was assessed by Western blotting. Telomerase activity was measured by the telomere repeats amplification protocol. EndoG overexpression reduced the expression of active full-length hTERT and increased the expression of inactive splice variant. Shifted balance of hTERT splice variants in cells led to a significant decrease in telomerase activity within 72 h after transfection.

Sobre autores

D. Zhdanov

Laboratory of Medical Biotechnology, V. N. Orekhovich Research Institute of Biomedical Chemistry

Autor responsável pela correspondência
Email: zhdanovdd@mail.ru
Rússia, Moscow

Yu. Gladilina

Laboratory of Medical Biotechnology, V. N. Orekhovich Research Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Rússia, Moscow

M. Pokrovskaya

Laboratory of Medical Biotechnology, V. N. Orekhovich Research Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Rússia, Moscow

S. Aleksandrova

Laboratory of Medical Biotechnology, V. N. Orekhovich Research Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Rússia, Moscow

D. Grishin

Laboratory of Medical Biotechnology, V. N. Orekhovich Research Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Rússia, Moscow

O. Podobed

Laboratory of Medical Biotechnology, V. N. Orekhovich Research Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Rússia, Moscow

N. Sokolov

Laboratory of Medical Biotechnology, V. N. Orekhovich Research Institute of Biomedical Chemistry

Email: zhdanovdd@mail.ru
Rússia, Moscow


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies